CA33009A - Liniment or medical compound for the cure of rheumatism, bruises, spinal disease, etc. - Google Patents

Liniment or medical compound for the cure of rheumatism, bruises, spinal disease, etc.

Info

Publication number
CA33009A
CA33009A CA000033009A CA33009DA CA33009A CA 33009 A CA33009 A CA 33009A CA 000033009 A CA000033009 A CA 000033009A CA 33009D A CA33009D A CA 33009DA CA 33009 A CA33009 A CA 33009A
Authority
CA
Canada
Prior art keywords
bruises
liniment
rheumatism
cure
spinal disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000033009A
Other languages
French (fr)
Inventor
Euphemia A. Mclennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Publication date
Application granted granted Critical
Publication of CA33009A publication Critical patent/CA33009A/en
Expired legal-status Critical Current

Links

CA000033009A Liniment or medical compound for the cure of rheumatism, bruises, spinal disease, etc. Expired CA33009A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA33009T

Publications (1)

Publication Number Publication Date
CA33009A true CA33009A (en) 1889-12-03

Family

ID=45149549

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000033009A Expired CA33009A (en) Liniment or medical compound for the cure of rheumatism, bruises, spinal disease, etc.

Country Status (1)

Country Link
CA (1) CA33009A (en)

Similar Documents

Publication Publication Date Title
EP4096752A4 (en) DISEASE TREATMENT SYSTEM WITH REDUNDANT OFFSET GLUCOSE SENSORS
ATE508114T1 (en) ISOINDOLYL COMPOUNDS SUBSTITUTED WITH N-ALKYLHYDROXAMIC ACIDS AND THEIR PHARMACEUTICAL USE
WO2020132658A3 (en) Tubulysins and protein-tubulysin conjugates
WO2019166412A9 (en) Modulation of pla2-g1b in therapy
WO2022106902A8 (en) Benzenesulfonamide derivatives and uses thereof
AU2024228957A1 (en) Hydroquinazoline derivatives for the treatment of a disease or disorder
WO2006058869A3 (en) Substituted pteridines for treating inflammatory diseases
MX2025014320A (en) Aromatic nitrogen-containing compounds, preparation methods and medicinal uses thereof
CA33009A (en) Liniment or medical compound for the cure of rheumatism, bruises, spinal disease, etc.
WO2023277583A8 (en) Novel plk1 protein degradation-inducing compound
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
EP3970710A4 (en) Pharmaceutical composition for preventing or treating degenerative brain diseases via autophagy activation
MX2007006357A (en) Substituted pteridines for treating inflammatory diseases.
BR112023000455A2 (en) TREATMENT OF INFLAMMATORY DISEASE USING ANTI-TISSUE FACTOR ANTIBODIES
CA3199014A1 (en) Combination therapy for the treatment of a liver disease
WO2024026129A3 (en) Tricyclic aryl derivatives, and compositions and methods thereof
WO2023240253A3 (en) Modulators of tnf-alpha activity
CA23971A (en) Medical compound for the cure of womb diseases, cancers, ulcers, scalds, etc.
EP4232438A4 (en) Compounds for the treatment of alzheimer's disease
BR112022021105A2 (en) DOSAGE REGIME TO TREAT A CSF-1R MODULATED DISEASE
MX2020007627A (en) Use of carrimycin or active ingredient thereof.
CA26293A (en) Medical compound for the cure of mitigation of all diseases of the skin
TH2203001132C3 (en) Herbal medicine formula from Kratom leaves for treating skin diseases, eczema, ringworm, scabies, jangkang.
CA31824A (en) Medical compound
CA3273570A1 (en) Phthalazinone based modulators for the treatment of disease